Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Alzheimers Dement. 2012 Oct 10;9(2):189–198. doi: 10.1016/j.jalz.2012.03.003

Table 1.

Clinical outcome measures for FTD clinical trials

Domain Clinical Syndromes Data collected from Test Longitudinal Data in FTD? Reference
General Cognitive bvFTD, SD, PNFA, CBS, PSPS Patient Addenbrooke's Cognitive Examination –Revised (ACE-R) Yes 1 2 3 4
bvFTD, SD, PNFA Patient Mini Mental State (MMSE) Yes 5,6
Executive function bvFTD, SD, PNFA, CBS, PSPS Patient EXAMINER Yes 7
bvFTD Informant Frontal Systems Behavior Evaluation (FrSBe) No 8
bvFTD, SD, PNFA, CBS, PSPS Patient Frontal Behavior Inventory Yes 6,9,10
ADL, IADL bvFTD, SD, PNFA Informant Disability Assessment for Dementia (DAD) Yes 11 12
bvFTD, SD, PNFA, Informant Clinical Dementia Rating Scale (CDR) Yes 5
bvFTD, SD, PNFA Patient Test of Everyday Functional Activities (TEFA) Yes 6
General bvFTD, SD, PNFA, PSPS Informant and Patient Clinicians Global Impression of Change (CGIC)/Clinical Global Impression of Severity (CGIS) Yes 5,13
Multiple Domains bvFTD, SD, PNFA Informant Frontotemporal Dementia Rating Scale (FRS) Yes 14
Neuropsychi atric bvFTD, SD, PNFA, CBS, PSPS Both Neuropsychiatric Inventory (NPI) Yes 6
bvFTD, SD, PNFA Informant Cambride Behavior Inventory No 15
Motor bvFTD, SD, PNFA, CBS, PSPS Patient Unified Parkinson's Disease Rating Scale Yes 6